PR9.BK SET
Praram 9 Hospital Public Company Limited
1W: -2.1%
1M: -2.1%
3M: +2.7%
YTD: -3.1%
1Y: -23.1%
3Y: +10.7%
5Y: +101.9%
฿18.90 ($0.56)
+0.10 (+0.53%)
Weekly Expected Move ±3.0%
฿18
฿18
฿19
฿19
฿20
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$7.0B
+9.8% ▲
5Y CAGR: +7.9%
Total Liabilities
$1.2B
+19.9% ▲
5Y CAGR: +11.1%
Shareholders Equity
$5.9B
+8.0% ▲
5Y CAGR: +7.4%
Cash & Investments
$2.7B
+19.6% ▲
5Y CAGR: +22.0%
Total Debt
$25M
+425.4% ▲
5Y CAGR: +26.3%
Net Debt
-$635M
-62.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $690M | $1.6B | $1.8B | $395M | $661M |
| Short-Term Investments | $554M | $152M | $151M | $1.8B | $2.0B |
| Cash & ST Investments | $1.2B | $1.7B | $1.9B | $2.2B | $2.7B |
| Net Receivables | $207M | $232M | $290M | $343M | $595M |
| Inventory | $56M | $51M | $48M | $57M | $65M |
| Other Current Assets | $5M | $23M | $12M | $15M | $20M |
| Total Current Assets | $1.6B | $2.0B | $2.3B | $2.7B | $3.4B |
| Property, Plant & Equip. | $3.4B | $3.2B | $3.3B | $3.2B | $3.4B |
| Goodwill & Intangibles | $100M | $78M | $80M | $80M | $116M |
| Long-Term Investments | $4M | $150M | $250M | $378M | $104M |
| Other Non-Current Assets | $5M | $9M | $8M | $18M | $15M |
| Total Non-Current Assets | $3.5B | $3.5B | $3.7B | $3.7B | $3.7B |
| Total Assets | $5.1B | $5.6B | $5.9B | $6.4B | $7.0B |
| — Liabilities — | |||||
| Accounts Payable | $140M | $151M | $150M | $238M | $233M |
| Short-Term Debt | $0 | $0 | $0 | $4M | $7M |
| Deferred Revenue | $105M | $2M | $5M | $0 | $0 |
| Other Current Liabilities | $257M | $240M | $247M | $56M | $355M |
| Total Current Liabilities | $667M | $610M | $632M | $758M | $880M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $9M |
| Other Non-Current Liab. | $190M | $209M | $195M | $202M | $253M |
| Total Non-Current Liabilities | $192M | $213M | $198M | $203M | $272M |
| Total Liabilities | $859M | $822M | $830M | $961M | $1.2B |
| — Equity — | |||||
| Common Stock | $786M | $786M | $786M | $786M | $786M |
| Retained Earnings | $1.5B | $1.9B | $2.3B | $2.6B | $3.1B |
| Accumulated OCI | $80M | $80M | $80M | $80M | $80M |
| Total Stockholders Equity | $4.3B | $4.7B | $5.1B | $5.4B | $5.9B |
| Total Liabilities & Equity | $5.1B | $5.6B | $5.9B | $6.4B | $7.0B |
| — Key Metrics — | |||||
| Total Debt | $6M | $8M | $9M | $5M | $25M |
| Net Debt | -$684M | -$1.6B | -$1.7B | -$390M | -$635M |
| Total Investments | $554M | $302M | $401M | $2.2B | $2.1B |